ELITE PHARMACEUTICALS INC /NV/ 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed May 21, 2015
Insider Transaction Report
Form 4
NIGALAYE ASHOK G
DirectorChief Scientific Officer10% Owner
Transactions
- Conversion
Common Stock
2015-05-21$0.06/sh+2,000,000$125,000→ 40,442,232 total - Conversion
Warrants
2015-05-21$0.06/sh−2,000,000$125,000→ 2,000,000 totalExercise: $0.06From: 2011-04-25Exp: 2018-04-25→ Common Stock (2,000,000 underlying)